Vinorelbine + mitomycin C as second-line treatment of metastatic breast cancer: A two-stage phase 2 study

Oncology

Volumn 58, Issue 1, 2000, Pages 8-14

  De Placido, S ^a   Lauria, R ^a   Perrone, F ^b   Vernaglia Lombardi, A ^a   Carlomagno, C ^a   Varriale, E ^a   Costanzo, R ^a   Leo, L ^a   De Laurentiis, M ^a   Bianco, A R ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Metastatic breast cancer; Mitomycin C; Phase 2 study; Second line chemotherapy; Vinorelbine

Indexed keywords

AMIKACIN; CEFOTAXIME; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; MITOMYCIN C; NAVELBINE; OFLOXACIN;

ABDOMINAL PAIN; ADULT; AGED; ANEMIA; ARTICLE; BONE PAIN; BREAST CANCER; BREAST METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; FEMALE; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; MYALGIA; NEPHROTOXICITY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SKIN TOXICITY; SURVIVAL TIME; THROMBOCYTOPENIA; VOMITING;

EID: 17444444679     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012072     Document Type: Article

References (16)

1. Perrone F, Carlomagno C, De Placido S, Lauria R, Morabito A, Bianco AR: First-line systemic therapy for metastatic breast cancer and management of pleural effusion. Ann Oncol 1995;6:1033-1043.
2. Pouillart P, Hoang HT, Brugerie E, Lheriter J: Sequential administration of two oncostatic drugs: Study of modalities for pharmadynamic potentiation. Biomedicine 1974;21:471-479.
3. Perrone F, De Placido S, Carlomagno C, Nuzzo F: Chemotherapy with mitomycin-C and vinblastine in pretreated metastatic breast cancer. Tumori 1993;80:254-257.
4. Nabholtz JM, Senn HJ, Bezwoda WR, McIn-chuk D, Deschenes L, Douma J, Vandenberg T, Rapoport B, Rosso R, Trillet-Lenoir V, Drbal J, Molino A, Nortier JWR, Richel DJ, Nagykalnai T, Siedlecki P, Wilking N, Genot JY, Hupperets PSGJ, Pannuti F, Skarlos D, Tomiak EM, Murawsky M, Alakl M, Riva A, Aapro M, on behalf of the international 304 study group: Prospective randomized trial of Docetaxel versus Mitomycin C plus Vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. J Clin Oncol 1999; 17:1413-1423.
5. Gasparini G, Caffo O, Barni S, Frontini L, Testolin A, Guglielmi RB, Ambrosini G: Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: A phase II study. J Clin Oncol 1994;12:2094-2101.
6. Degardin M, Bonneterre J, Hecquet B, Pion JM, Adenis A, Horner D, Demaille A: Vinorelbine (navelbine) as a salvage treatment for advanced breast cancer. Ann Oncol 1994;5: 423-426.
7. Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer 1981;47:207-214.
8. Simon R: Optimal two-stage designs for phase II clinical trials. Control Clin Trials 1989;10: 1-10.
9. Kaplan EL, Meier P: Non parametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-481.
10. Dixon WJ: BMDP Statistical Software. Los Angeles, University of California Press, 1992.
11. Cox DR: Regression models and life tables. J R Stat Soc 1972;B34:187-220.
12. Scheithauer W, Kornek G, Haider K, Kwasny W, Schenk T, Pirker R, Depisch D: Effective second-line chemotherapy of advanced breast cancer with navelbine and mitomycin C. Breast Cancer Res Treat 1993;26:49-53.
13. Agostara B, Gebbia V, Testa A, Cusimano MP, Gebbia N, Callari AM: Mitomycin C and vinorelbine as second-line chemotherapy for metastatic breast carcinoma. Tumori 1994;80: 33-36.
14. Vici P, Di Laura L, Carpano S, Amodio A, Pignatti F, Casali A, Conti F, Lopez M: Vinorelbine and mitomycin C in anthracycline-pretreated patients with advanced breast cancer. Oncology 1996;53:16-18.
15. Colleoni M, Manente P, Stocker J, Amor H, Lamon S, Nelli P, Vicario G, Sgarbossa G, Graiff C: Mitomycin C and vinorelbine in pretreated breast cancer. Tumori 1997;83:834-836.
16. Kornek GV, Haider K, Kwasny W, Hejna M, Raderer M, Meghdadi S, Burger D, Schneeweiss B, Depisch D, Scheithauer W: Effective treatment of advanced breast cancer with vinorelbine, mitomycin C plus human granulocyte colony-stimulating factor. Br J Cancer 1996;74:1668-1673.